Results
Kilitch Drugs Q2 Net Profit Declines 53% YoY
Kilitch Drugs approved Q2 FY27 standalone and consolidated unaudited financial results, showing a significant YoY decline in net profit.
The Board approved the divestment of material subsidiary Kilitc
